Cell
The development and optimization of in-house CAR T generation and manufacturing procedure
12 Oct
15:30
-
16:10
Speakers
.jpg)
About the Session
- A short introduction
- Generation and characterization of an in-house humanized CD19 CAR lentiviral vector in vitro and in preclinical animal model.
- Identification of a novel agent that serves as a soluble transduction enhancer.
- Driving CAR-T manufacture optimization process.
